IPHARM SOLUTIONS LTD

Company number 06430440 ·

Active - Proposal to Strike off

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£50k -£25k £0 £25k £50k £75k £100k £125k £150k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £132,479 Total assets 2017: £120,221 Total assets 2018: £83,460 Total assets 2019: £81,959 Total assets 2020: £41,150 Total assets 2021: £50,921 Total assets 2022: £36,647 Total assets 2023: £21,378 Total assets 2024: £13,580 Total assets 2025: £0 Total assets Net assets 2016: £84,474 Net assets 2017: £91,521 Net assets 2018: £66,942 Net assets 2019: £58,130 Net assets 2020: £30,712 Net assets 2021: £7,455 Net assets 2022: £1,454 Net assets 2023: -£5,937 Net assets 2024: -£6,215 Net assets 2025: -£6,215 Net assets Total liabilities 2016: -£47,298 Total liabilities 2017: -£28,163 Total liabilities 2018: -£15,934 Total liabilities 2019: -£23,362 Total liabilities 2020: -£10,064 Total liabilities 2021: -£29,400 Total liabilities 2022: -£22,200 Total liabilities 2023: -£19,585 Total liabilities 2024: -£19,795 Total liabilities 2025: -£6,215 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Balance sheet by year 15 years

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-11-30 £0 -£6,215 -£6,215
2024-11-30 £13,580 -£19,795 -£6,215
2023-11-30 £21,378 -£19,585 -£5,937 £1,575
2022-11-30 £36,647 -£22,200 £1,454 £14,186
2021-11-30 £50,921 -£29,400 £7,455 £37,018
2020-11-30 £41,150 -£10,064 £30,712 £25,063
2019-11-30 £81,959 -£23,362 £58,130 £49,622
2018-11-30 £83,460 -£15,934 £66,942 £44,525
2017-11-30 £120,221 -£28,163 £91,521 £93,420
2016-11-30 £132,479 -£47,298 £84,474 £98,378
2015-11-30 £202,718 -£56,179 £149,845 £161,096
2014-11-30 £89,554 -£29,095 £64,993 £65,984
2013-11-30 £135,911 -£75,506 £60,289
2012-11-30 £46,399 -£13,063 £33,220 £1,558
2011-11-30 £46,399 -£13,063 £33,220 £1,558

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.